Exousia Bio, Inc. (LMMY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-31. Amounts in USD.

Revenue Quarterly

0 1.5K 3K 4.5K Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 3.9K Q3 '24: 3.9K Q4 '24: 3.8K Q1 '25: 3.8K Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q3 '26: 0 Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Gross Profit Quarterly

-75K -50K -25K 0 25K 50K 75K Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 3.9K Q3 '24: 3.9K Q4 '24: -5.9K Q1 '25: 3.8K Q2 '25: 0 Q3 '25: 0 Q4 '25: -7.3K Q1 '26: 0 Q2 '26: -62.1K Q3 '26: 0 Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Operating Income Quarterly

-270K -180K -90K 0 90K 180K 270K Q1 '23: -13K Q2 '23: -8.4K Q3 '23: -8.3K Q4 '23: -26.8K Q1 '24: -12.2K Q2 '24: -7.4K Q3 '24: -8.7K Q1 '25: -4.3K Q2 '25: 7K Q3 '25: 0 Q1 '26: -31.8K Q2 '26: -237K Q3 '26: 0 Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26 Q3 '26

Net Income Quarterly

-90K -60K -30K 0 30K 60K 90K Q1 '23: -13K Q2 '23: -8.4K Q3 '23: -8.3K Q4 '23: -26.8K Q1 '24: -12.2K Q2 '24: -3.6K Q3 '24: -4.8K Q4 '24: -5.3K Q1 '25: -3.9K Q2 '25: 80.1K Q3 '25: 61.8K Q4 '25: -86.7K Q1 '26: -31.8K Q2 '26: -19.1K Q3 '26: 0 Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Cost of Revenue Quarterly

0 25K 50K 75K Q1 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 7.3K Q1 '26: 0 Q2 '26: 62.1K Q3 '26: 0 Q1 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Operating Cash Flow Quarterly

-60K 0 60K 120K 180K Q1 '23: -9.3K Q2 '23: -4.7K Q3 '23: -1.6K Q4 '23: -22.5K Q1 '24: -8K Q2 '24: -1.7K Q3 '24: -1.4K Q4 '24: -1.4K Q1 '25: -3.7K Q2 '25: 90.2K Q3 '25: 0 Q1 '26: 3.5K Q2 '26: 173.1K Q3 '26: 0 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q1 '26 Q3 '26

Free Cash Flow Quarterly

0 Q3 '25: 0 Q3 '26: 0 Q3 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q1 '23: 5M Q2 '23: 5M Q3 '23: 5.3M Q1 '24: 7.8M Q2 '24: 7M Q3 '24: 7.8M Q1 '25: 7.8M Q2 '25: 7.8M Q1 '26: 7.8M Q2 '26: 16.8M Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.00 0.01 0.01 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.01 Q3 '25: 0.01 Q4 '25: 0.01 Q1 '26: 0.01 Q2 '26: 0.00 Q3 '26: 0.00 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.